Publications
-
Prevalence and Mortality Trends of Hemoglobinopathies in Italy: A Nationwide Study
Abstract Not available.
Read More » -
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022: Epidemiology and Impact on Clinical Events
In 2015, Catalonia introduced sickle cell disease (SCD) screening in its newborn screening (NBS) program along with standard-of-care treatments like penicillin, hydroxyurea, and anti-pneumococcal vaccination. Few studies have assessed the…
Read More » -
Management of Transfusion-Dependent β-Thalassemia (TDT): Expert Insights and Practical Overview from the Middle East
β-Thalassaemia is one of the most common monogenetic diseases worldwide, with a particularly high prevalence in the Middle East region. As such, we have developed long-standing experience with disease management…
Read More » -
Challenges of Iron Chelation in Thalassemic Children
Thalassaemia treatment still relies on supportive care, mainly including blood transfusion and iron chelation therapy. Iron chelation is considered the main factor responsible for the marked improvement in survival rates…
Read More » -
Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (5th edition – 2025)
Taher, A.T. Farmakis, D. Porter, J.B. Cappellini, M.D. Musallam, K.M.
Read More » -
EU Policies Made Simple – Factsheet Series
A series of factsheets that offer an easy-to-understand overview of what Europe has achieved so far in key health policy areas, such as Access to Drugs, Cross Boarder Healthcare, and…
Read More » -
TIF Literature
Assessing Disability in Thalassaemia: A Position Statement by the Thalassaemia International Federation Farmakis, D., Angastiniotis, M., Papingiotis, G., Cannon, L., & Eleftheriou, A. European Journal of Haematology.(2024). Exciting Science from…
Read More » -
Iron Chelation Therapy for Children with Transfusion‐Dependent β‐Thalassemia: How Young Is Too Young?
In this review, we provide a summary of evidence on iron overload in young children with transfusion-dependent β-thalassemia (TDT) and explore the ideal timing for intervention. Key data from clinical…
Read More » -
Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies
Hemoglobinopathies are monogenic disorders affecting hemoglobin synthesis. Thalassemia and sickle cell disease (SCD) are considered the two major hemoglobinopathies. Thalassemia is a genetic disorder and one of the major hemoglobinopathies…
Read More » -
Early Detection of Renal Complication in Children With Sickle Cell Disease: A Single Center Prospective Study
Introduction: This observational cross-sectional study aimed to identify predictors of renal complications in pediatric patients with sickle cell disease (SCD) at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia, over…
Read More »